Deciding how to decide: Deciding how to decide: The added ...
AOHP ONLINE EDUCATION PROGRAM 2013WEB005 -INJECTION SAFETY ... › ... ›...
Transcript of AOHP ONLINE EDUCATION PROGRAM 2013WEB005 -INJECTION SAFETY ... › ... ›...
AOHP ONLINE EDUCATION PROGRAM
2013WEB005 - INJECTION SAFETY
FOR PATIENTS AND HEALTHCARE FOR PATIENTS AND HEALTHCARE
WORKERS
NICOLE NOMIDES, MT(ASCP), MS, CIC
UNIVERSITY OF MICHIGAN
INFECTION CONTROL & EPIDEMIOLOGY
Disclosure
Thank you for participating in this continuing educational activity.
Goals/Purpose : To improve knowledge that promotes professional development
and enhance the learners contribution of quality health care in
Employee/Occupational Health.
Successful Completion of this CNE
In order to receive full contact-hour credit for this CNE activity, you must:
����Attend the full session
���� Complete an evaluation
Conflict of Interest (or lack thereof) for Planners & Presenter(s) Conflict of Interest (or lack thereof) for Planners & Presenter(s)
A conflict of interest occurs when an individual has opportunity to affect or
impact educational content with which he or she may have a commercial interest
or a potentially biasing relationship of a financial, professional or personal nature.
All planner and faculty/content specialist(s) must disclose the presence or
absence of a conflict of interest relative to this activity. All potential conflicts are
resolved prior to the planning, implementation or evaluation of the continuing
nursing education activity. All activity planning committee members and
faculty/content specialist have submitted conflict of interest disclosure forms.
The planning committee members and faculty/content specialist of this CNE
activity have disclosed no relevant professional, personal or financial
relationships related to the planning or implementation of the CE activity.
Disclosure (Continued)
Commercial or Sponsor support
This CNE activity received no sponsorships or commercial support.
Non-endorsement of products
The approved provider status of AOHP (Association of Occupational Health
Professionals) refers only to the continuing nursing education activity and does
not imply a real or implied endorsement by
AOHP or the American Nurses Credentialing Center (ANCC) of any commercial
product, service or company referred to or displayed in conjunction with this
activity, nor any company subsidizing costs related to this activity.
Reporting of Perceived BiasReporting of Perceived Bias
Bias is defined by the American Nurses Credentialing Center’s Commission on
Accreditation (ANCC COA) a preferential influence that causes a distortion of
opinion or of facts. Commercial bias may occur when a CNE activity promotes one
or more products(s)( drugs, devices, serviced, software, hardware, etc,). This
definition is not all inclusive and participants may use their own interpretation in
deciding if a presentation is biased.
The Association of Occupational Health Professionals in Healthcare is accredited as a provider of continuing nursing education by the American Nurses
Credentialing Center’s Commission on Accreditation.
OVERVIEW OF PRESENTATION
• Incidents and outbreaks of infections during routine healthcare
procedures involving intravenous injections
• Survey identified unsafe injection practices among a small
percentage of US clinicians
• Prevention strategies include oversight and enforcement of safe
practices AND education and empowerment of both patients practices AND education and empowerment of both patients
and healthcare providers
• US national initiative to educate providers and public: Safe
Injection Practices Coalition (SIPC) and its One and Only
Campaign
WHAT IS INJECTION SAFETY?
Injections include:
• Intradermal, subcutaneous and intramuscular needle injections
• Intravenous (IV) infusions and injections
• Dental injections
• Phlebotomy and lancet (surgical) procedures
According to World Health Organization, a safe injection is one that:According to World Health Organization, a safe injection is one that:
• Does not harm the recipient
• Does not expose the provider to any avoidable risk
• Does not result in any waste that is dangerous for other people
Part of Standard Precautions
Infection prevention practices that apply to all patients, regardless
of suspected or confirmed infection status, in any healthcare setting
WORLD HEALTH ORGANIZATION AND SAFE INJECTION
GLOBAL NETWORK ISSUE TOOLKIT FOR SAFE
INJECTION PRACTICES, 2010
Includes prevention of
harm to both
Patients Patients
AND
Healthcare Workers
OUTBREAKS IN THE US
Medical assistant administered flu vaccine from the same syringe to more than1 patient
ERA OF DECREASING ACUTE
HBV/HCV INCIDENCE
•HIV prevention•Hepatitis B vaccine•Screening of blood donors •Healthcare worker safety
Decline in healthcare transmission
HBV
CDC. Surveillance for Acute Viral Hepatitis – United States, 2007. MMWR 2009;58 (No. SS-3).
Est. new cases
43,000
17,000
HCV
SEEING INCREASE IN VIRAL HEPATITIS
OUTBREAKS ASSOCIATED WITH
HEALTHCARE PROCEDURES
Once considered uncommon in US
• Not identified via acute HBV/HCV surveillance data
Over past decade, increase in the number, size of
outbreak investigations, number of persons affectedoutbreak investigations, number of persons affected
Increase in attention
• Public, media, public health officials, healthcare providers/professional organizations
OUTBREAKS DUE TO UNSAFE INJECTION PRACTICES
Steady increase in detected outbreaks from unsafe injection practices,
Over 20 outbreaks involving bacterial pathogens, typically resulting in bloodstream infections and requiring prolonged hospitalization and IV antibiotics
Over 80 outbreaks of hepatitis B or C have occurred in healthcare settings
• Majority in non-hospital settings: long-term care, outpatient, hemodialysis, MD office, pain clinic, endoscopy clinic• Majority from unsafe injection practices or breakdown in infection control - aseptic practices• Requiring notification of thousands of patients
HEALTHCARE-ASSOCIATED HBV/HCV OUTBREAKS
BY YEAR REPORTED – US 1998 TO 2012
4
6
8
10
12
Nu
mb
er
of
Ou
tbre
aks
72 total outbreaks (61 non-hospital):• 28 long-term care• 21 outpatient clinics• 12 hemodialysis facilities• 11 hospitals
0
2Nu
mb
er
of
Ou
tbre
aks
http://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm
Hepatitis Outbreaks in Outpatient Clinic Settings due to Unsafe Injection Practices
1998-2008
State Setting Year Type
NY Private MD office 2001 HCV
NY Private MD office 2001 HBV
NE Oncology clinic 2002 HCV
OK Pain remediation clinic 2002 HBV+HCV
NY Endoscopy clinic 2002 HCV
CA Pain remediation clinic 2003 HCV
MD Nuclear imaging 2004 HCV
FL Alternative medicine clinic 2005 HBV
CA Alternative medicine clinic 2005 HCV
NY Endoscopy/surgery clinics 2006 HCV
NY Pain remediation clinic 2007 HCV
NV Endoscopy clinic 2008 HCV
NC Cardiology clinic 2008 HCV
Thompson, Annals Int Med, 2009
US SURGICAL PROCEDURES MOVING FROM
INPATIENT TO OUTPATIENT SETTING
30
35
40
45Outpatient
Pro
ced
ure
s (
mil
lio
ns)
0
5
10
15
20
25
30
Inpatient
Pro
ced
ure
s (
mil
lio
ns)
UNSAFE INJECTION PRACTICES
ASSOCIATED WITH A VARIETY OF
PROCEDURES IN U.S.
• Anesthesia for outpatient surgical, diagnostic and pain management procedures
• Administration of other IV medications including chemotherapy, cosmetic procedures and alternative medicine (e.g., chelation therapy, alternative medicine (e.g., chelation therapy, vitamins/steroids)
• Flushing IV lines or catheters
• Vaccination
• Administration of contrast media
OUTBREAKS DO NOT TELL THE FULL
STORY
Identified outbreaks
Asymptomatic
infection
Difficulty
identifying
single
healthcare
exposure
Under-
reporting of
cases
Under-
recognition of
healthcare as
risk
Sporadic
transmission
exposure
Barriers to
investigation
(e.g., resource
constraints)
DIRECT SYRINGE REUSE
OKLAHOMA HOSPITAL-BASED PAIN
CLINIC, 2002
102 cases (71 with HCV and 31 with HBV)
• Filled syringes of midazolam, fentanyl, and propofol with enough medication to treat up to 25 patientsmedication to treat up to 25 patients
• Reused these syringes to inject into heparin lock attached directly to an IV
• Contract anesthesia staff (1day/wk)
• $25 million settlement
Comstock et al. ICHE 2004;25:576-583; CDC MMWR 2003 (52):38
“Did, did you just double dip that
chip?” Timmy asks incredulously, “That’s like putting your whole
mouth right in the dip!”
Slide courtesy of Dr. Joseph Perz, CDC
“INDIRECT” SYRINGE REUSE OR
DOUBLE DIPPING
Accessing vials with a used syringe and reuse of the
vial or container for additional patients
• Single dose medications commonly involved•Single dose medications commonly involved
•Accounts for the majority of viral hepatitis outbreaks due to unsafe injections
INDIRECT TRANSMISSION OF HBV
Transmission via
contaminated
Stable in environment
for at least 7 days1
contaminated
surfaces/equipment
High viral titer: virus
present in absence
of visible blood2
1: Bond et al. Lancet 1981; 8219:550-12: Shikata et al. J Infect Dis 1977;136:571–76
INDIRECT SYRINGE REUSE
NEBRASKA – ONCOLOGY CLINIC, 2002
99 cases of HCV
Nurse drew blood from IV catheter, then
reused same syringe to obtain saline from
IV bag and perform a flush IV bag and perform a flush
• New syringe was used for each patient
• Solution from 500cc bag used for multiple patients
• No active infection control program
Macedo de Oliveira et al., Annals of Internal Medicine, 2005, 142:898-902
INDIRECT SYRINGE REUSE AND VIAL
CONTAMINATION
LAS VEGAS NEVADA ENDOSCOPY CLINIC
115 cases of HCV
Clinics performed 50-60 procedures/day
• Anesthesia induction with syringe of lidocaine (1cc) and propofol (9ccs)-Clean lidocaine (1cc) and propofol (9ccs)-Clean needle/ syringe to inject into IV catheter
• If patient needed more anesthesia, some providers changed needle but used same syringe to draw more propofol
• Contaminated propofol vial used to sedate next patient
MMWR; May 16, 2008; 57:19
NEVADA OUTBREAK – EPILOGUE
License revoked and clinic was closed
Unsafe practices had been commonly used by some staff at the
clinic for at least 4 years
• Health department notified 63,000 persons to recommend HBV, HCV, HIV screeningHCV, HIV screening
Prompted assessments of infection control practices at all licensed
ambulatory surgical centers
INSULIN PEN REUSE INCIDENTS
Incidents in which insulin pens were reused for multiple
patients, reportedly after changing needles
NY hospital, 2008
TX hospital, 2009
cdc.gov/injectionsafety
Jan 2012www.cdc.gov/injectionsafety
HBV TRANSMISSION ASSOCIATED WITH
GLUCOSE MONITORING DEVICES
• Higher risk of transmission of hepatitis associated with “on-meter” test strip (patient’s finger touches test strip on the machine)
• Survey found 30% of glucometers • Survey found 30% of glucometers had blood contamination
• Most facilities do not clean after each use as recommended
• Failure to clean and disinfect unit between patients may also lead to glove contamination
SYRINGE REUSE AND LAX INFECTION
CONTROL
CALIFORNIA PAIN CLINIC, 2010
2 confirmed cases HBV and HCV; (19 potential cases)
2,300 patients notified
Re-entry of multidose vials with contaminated syringe
to get additional doses for same patient and then to get additional doses for same patient and then
returned vial to the cart for reuse.
• Reuse of single dose vials of contrast (Omnipaque) for multiple patients
Lax infection control
• No masks during neuraxial procedures
LA County California Health Department Report, June 2011
HEPATITIS B OUTBREAK NEW YORK CITY,
38 CASES HBV FROM LAX INFECTION CONTROL PRACTICES
• Most injections given by medical technicians
• All multi-dose vials used
• Contaminated syringes left on same table where meds prepared
• Likely contamination of tops of vials during syringe disassembly
Infect Control Hosp Epidemiol 2005; 26: 745-60
CONTAMINATED MEDICATION
PREPARATION AREA
NEW YORK DOCTOR’S OFFICE
• 38 cases of HBV
• Most injections given by medical technicians
• All multi-dose vials used
• Contaminated syringes left on same table where medications prepared
• Likely contamination of tops of vials during syringe disassembly
Samardurai T. Infect Control Hosp Epidemiol 2005; 26: 745-60
Storage of multi-dose vials and
preparation of injections in same
area that used needles and syringes
were dismantled and discarded
FACT: injection preparation on surfaces where contaminated
substances are handled can lead to the spread of infections
Ref: Samandari et al. ICHE 2005; 26: 745-750
Photo: Don Weiss / NYCDOHMH
AND….
NOT JUST VIRAL BLOODBORNE
PATHOGENS!
REUSE OF SINGLE DOSE VIALS OF CONTRAST AGENTS
BACTERIAL INFECTIONS- OUTBREAKS
’05 MA: 7 cases S marcescens
‘08 FL: 7 cases – Mycobacterium abscessus *
‘08 FL: 24 cases – invasive S. aureus *
‘08 NYC: 9 cases – K pneumoniae & Enterobacter
‘09 WV: 8 cases – invasive S. aureus
‘09 CA: 7 cases – invasive S. aureus
*Patients required laminectomy
UNSAFE INJECTION PRACTICES ARE COSTLY TO
PATIENTS,
PROVIDERS, AND HEALTH DEPARTMENTS
Unsafe injection practices have resulted in:
• Transmission of life-threatening infections, including hepatitis C virus, to patients
• Notification of thousands of patients of possible exposure to bloodborne pathogens and recommendation that they undergo testing
• Referral of providers to licensing boards for disciplinary action • Referral of providers to licensing boards for disciplinary action
• Malpractice suits filed by patients
WHAT CAN WE DO
ABOUT IT?
SURVEY OF INJECTION PRACTICES
AMONG CLINICIANS IN US HEALTHCARE
SETTINGS, 2011
5,500 respondents
Practice setting:
• Hospital setting 66%• Non-hospital setting 34%
Department or area:
• General pt care 25%• Surgery-anesthesia 18%• Critical care 16%• Endoscopy 6%• Emergency care 7%• Oncology 3%• Pain management 2%• Radiology/Radiation 2%
Pugliese G, Gosnell C, Bartley JM, Robinson S. Am J Infect Control Dec 2010
SURVEY OF INJECTION PRACTICES AMONG
CLINICIANS IN US HEALTHCARE SETTINGS,
2011Professional Training:
Registered Nurses 4,570
Licenses practical nurses 145
Anesthesiology assistants 120
Physicians 120Physicians 120
Anesthetists (CRNA) 49
Patient care technicians 35
Pharmacists 23
Laboratory technologists 13
Respiratory therapy 10
OR technician 10
Dentists 9
SURVEY OF INJECTION PRACTICES AMONG
CLINICIANS IN US HEALTHCARE SETTINGS, 2011
Results:
• 1% “sometimes or always” reuse a
syringe for a second patient
• 1% “sometimes or always” re-enter a
multidose vial with a contaminated
syringe and safe vial for reusesyringe and safe vial for reuse
• 6% use single-dose vial for more than
one patient
• 8% use a bag/bottle of intravenous
solution as a source for medication
diluent/flush for multiple patients
Pugliese G, Gosnell C, Bartley JM, Robinson S. Am J Infect Control Dec 2010
MISTAKEN BELIEFS ABOUT PRACTICES
TO PREVENT CONTAMINATION AND
INFECTION TRANSMISSION
• Changing the needle
between patients (not the
syringe)
• Injecting through IV tubing• Injecting through IV tubing
• Maintaining pressure on the
plunger to prevent backflow
• Lack of visible blood
• Large single-dose vials are
ok for more than one
patient
VIAL SIZE AND LABELING ADDS
CONFUSION
xxxx
Single doseSingle dose bottle
Photo: Don Weiss, NYCDOMH
WHAT LIES IN DRAWERS?
Pre-drawn up syringes –
preparing for next case (Pharmacy costs and supply issues lead to this)
CREATIVITYCREATIVITYCREATIVITYCREATIVITY
“HOW DO YOU KNOW ?”
Pre-dated M > 24 hrs. ?
Empty syringes M Used ?
• Cost containment and the drive for
efficiency
• Increase care in outpatient care settings
where infection control programs
lacking and less oversight
CHALLENGES
• Old ingrained behaviors – “force of
habit” not based on current knowledge
• Lack of safety culture and
empowerment to “speak up”
• Myths about sterile technique and
contamination risks
DRUG SHORTAGES PROMPT PHYSICIANS TO PUSH
FOR RE-USE OF SINGLE-DOSE VIALS
OVERSIGHT, ENFORCEMENT,
EDUCATION
US government and its agencies and accreditation organizations are strengthening regulations, standards, guidelines and inspections across all healthcare settings
• Particular focus on infection control including injection safety in ambulatory , outpatient and oncology careambulatory , outpatient and oncology care
• Worksheets and checklists to assess practices
LAPSES IN INFECTION CONTROL
COMMON IN SURVEY OF AMBULATORY
SURGICAL CENTERS
67% (46 of 68 ASCs) had at least one lapse in infection control
17% had 3 or more lapses
Most common lapses -Most common lapses -
• Using single-dose medication vials for more than 1 patient
• Improper reprocessing of equipment
• Mishandling of blood glucose monitoring equipment
Schaeffer MK, Infection control assessment of ambulatory surgical centers JAMA.
2010;303(22):2273-70
INFECTION CONTROL WORKSHEET
COMPONENTS
FOR AMBULATORY SURGICAL CENTERS
� Elements from CDC/HICPAC Guidelines
� Emphasis on Standard Precautions
� Injection safety and medication handling
� Hand hygiene and glove use
� Instrument reprocessing
� High-level disinfection (e.g., endoscope reprocessing)
� Sterilization
� Environmental cleaning
� Point-of-care devices (e.g., blood glucose meters)
www.premierinc.com/injectionpractices
INFECTION CONTROL WORKSHEET FOR LICENSED FACILITIES
(DOWNLOAD AT PREMIERINC.COM/INJECTIONPRACTICES)
http://www.cms.gov/manuals/downloads/som107_exhibit_351.pdf
SURVEY TOOL ADAPTED FROM APIC SAFE
INJECTIONS PRACTICES POSITION PAPER
SAFE INJECTION PRACTICES
EVIDENCE-BASED GUIDELINES
EDUCATIONAL RESOURCES AND EDUCATIONAL RESOURCES AND
TOOLS
www.cdc.gov/injectionsafety
Frequently asked
Questions:
• Medication preparation• Single-dose-single-use vials• Multi-dose vials
www.cdc.gov/injectionsafety
www.cdc.gov/HAI/settings/outpatient/outpatient-settings.html
CDC RELEASED GUIDE AND CHECKLIST
FOR OUTPATIENT SETTINGS, JULY 2011
CDC’S NEW PROGRAM, PREVENTING
INFECTIONS IN CANCER PATIENTS, NOV 2011WWW.CDC.GOV/CANCER/PREVENTINFECTIONS/
Includes:
Basic Infection Control Plan
Interactive website for patients, caregivers, healthcare providers
SAFE INJECTION PRACTICES
COALITION (SIPC)
SIPC• Established in 2008• Established in 2008• Led by CDC• Partnership of healthcare organizations
• Launched “One and Only Campaign”
www.oneandonlycampaign.org
Injection Safety is Every Provider’s responsibility
Safe Injection Practices Coalitionwww.oneandonlycampaign.org
The One & Only Campaign – a public health education and
awareness campaign – aimed at both healthcare providers and
patients to advance and promote safe injection practices
Safe Injection Practices Coalitionwww.oneandonlycampaign.org
The One & Only Campaign
•Tools
•Posters, brochures
•Educational materials
•Videos and Smart phone app
for training
•Research findings
SIPC PROVIDER TRAINING VIDEO
Three settings where
medications are prepared
and administered: an
operating room, an
oncology clinic, and a pain
management clinicmanagement clinic
Outlines and corrects
myths and misperceptions
that healthcare providers
may have about safe
injection practices www.premierinc.com/safetystore
DOWNLOAD BROCHURES, POCKET GUIDES,
POSTERS, SLIDES AT
www.cdc.gov/injectionsafety
CDC MEDSCAPE COMMENTARY
Discusses myths and misperceptions
about safe injection practices:
• Removing needle makes syringe safe
to reuse (Not true)
• IV tubing or valves guarantee
against contamination (Not true)against contamination (Not true)
• Lack of visible blood = lack of
contamination (Not true)
• Large single dose vials can be used
for >1 patient (Not true)
www.medscape.com/viewarticle/735593
PREMIER AND SIPC MEETING, 2011
Providers, manufacturers,
inventors, unions, professional
organizations, government met to
raise awareness and continue
dialogue on safer and innovative dialogue on safer and innovative
approaches and designsM
Download proceedings at:
www.premierinc.com/injectionpractices
Adherence to Safe Injection Practices and Basic Infection Control Needs to Extend Across the Entire Healthcare Continuum
Tranquil GardensNursing Home
HomeCare
Acute CareFacility
Outpatient/AmbulatoryFacility
Long Term CareFacility
WHAT’S NEXT???WHAT’S NEXT???
HEPATITIS C OUTBREAK, COLORADO HOSPITAL 2009
“INJECTION SAFETY MEETS NARCOTICS SECURITY…”
2009 Colorado Hospital
• 24 patients with HCV infection
• HCV-infected surgery technician stole unattended fentanyl syringes, stole unattended fentanyl syringes, injected self, and refilled contaminated syringe with saline
• 6,000 patients were notified
• Technician convicted and serving 30 year prison term
DIVERTER CASES RESULTING IN HCV
TRANSMISSION
In Colorado, a surgical tech accessed narcotic vials in the OR from the Anesthesia carts; infected 37 patients with her HCV
K.Parker; serving 30 yr. prison term
In Florida an IR tech infected 5 patients with their HCV
IR tech responsible for at least 35 cases of HCV in 9 states; exposed 1000’s of patients
CURBING DRUG DIVERSION
•TIGHT INSTITUTIONAL POLICIES AROUND
DRUG-FREE WORKPLACE
•DRUG TESTING ?
•PATIENT SAFETY FOLLOW UP WHEN DIVERTOR
IDENTIFIED ?
•LICENSING AND CERTIFICATION •LICENSING AND CERTIFICATION
•FLAGGING OFFENDERS
•STATE AND FEDERAL LEGISLATION?
http://www.naddi.org
SOMEDAY IS NOT A DAY OF THE WEEK
• Bloodborne pathogens- HAI surveillance ?
• Routine safe injection practice surveys of clinical areas
• Routine reporting by providers and • Routine reporting by providers and non-punitive response
• Audits and provider-level timely feedback
• Routine disclosure and testing of potentially exposed patients
• Testing IV diverters for BBP
ACKNOWLEDGEMENTS
Joseph Perz , CDC, Division of Healthcare Quality Promotion
Melissa Schaefer, CDC, Division of Healthcare Quality Promotion
Nicola Thompson, CDC, Division of Healthcare Quality Promotion
Alice Guh, CDC, Division of Healthcare Quality Promotion
Karen Weiss, FDAKaren Weiss, FDA
Gina Pugliesi, Premier Safety Institute
Cathie Gosnell, Premier Safety Institute
Scott Robinson, Premier Research Services
Lisa Sturm, University of Michigan Hospitals and Health Centers
THANK YOU!